← Every firm
Novitium Pharma LLC FDA Recalls
2 recalls on file across drugs, 0 of them Class I and 0 still open. This firm is not matched to a listed company.
Newest first
Class I is the FDA's most serious grade: a reasonable probability of serious harm or death.
| Product |
|---|
| Digoxin Tablets, USP 62.5 mcg (0.0625 mg), 100-count bottles, Rx Only, Manufactured by: Novitium Pharma LLC, 70 Lake DriClass IIIMar 25, 2024Failed Impurities/Degradation Specifications |
| Digoxin Tablets, USP 125mcg, (0.125 mg), 1000-count bottle, Rx Only, Manufactured by: Novitium Pharma LLC., 70 Lake DrivClass IIIMar 4, 2024Cross Contamination with Other Products:(mycophenolate mofet |